CALGB/ECOG 100104 (Alliance) Study: Lenalidomide (LEN) vs Placebo (PBO) Maintenance (Maint) After Stem Cell Transplant (SCT) for Patients (Pts) With Multiple Myeloma: Overall Survival (OS) and Progression-Free Survival (PFS) Adjusted for Treatment (Tx) Crossover (XO)
- Citation:
- J Clin Oncol vol 35 (15 suppl) abstr 8037
- Meeting Instance:
- ASCO 2017
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, CA180820
- Corr. Author:
- Authors:
- Philip L. McCarthy Sarah A. Holstein Sin-Ho Jung Miranda Cooper Craig J. Gibson Edward A. Stadtmauer Benjamin Winograd Paul Richardson
- Networks:
- LAPS-MA036, LAPS-NY158, NE003
- Study
- CALGB-100104
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: